Brand new peer-reviewed data on Eli Lilly’s candidate tirzepatide has set the stage for a battle within the obesity market. Novo Nordisk vs Eli Lilly. Tirzepatide vs semaglutide. The US vs Denmark.
US-based industry media Fierce Pharma reports that Eli Lilly’s tirzepatide met both primary and secondary endpoints in its phase III trial Surmount 1, and demonstrated a weight loss of up to 22.5% after 72 weeks of treatment. The data was published in the New England Journal of Medicine.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Leo Pharma eczema treatment recommended in two UK countries
After postponing the decision in April, the British medicines council NICE has now ruled that Adtralza can be recommended to treat atopic dermatitis.
Fujifilm invests USD 1.5bn in Danish factory
Japanese firm Fujifilm Diosynth Biotechnologies is investing DKK 11bn (USD 1.5bn) in its factor in Northern Zealand, Denmark. The expansion will provide 450 jobs.
Life science firms are planning USD 6.3bn construction spree in Denmark
Fujifilm’s expansion to its factory in Hillerød means that the life science sector has announced DKK 12bn (USD 1.7bn) in facility investments in Denmark since May.
Sanofi reduces US insulin prices for the uninsured
While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.
Specialist within Project Management and Launch, Regulatory Affairs Life Cycle Management 
Regulatory Affairs Manager - Maternity Cover 
Director Regulatory Affairs 
Medical Advisor 
Project Mgr for Medical Device Development 
Senior Scientist for Analytical Development 
Global Product Manager - Pulmonology 
QA Senior Specialist 
Principal Laboratory Technologist Medicinal Chemistry 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Nordic Medical Advisor